Production (Stage)
Bolt Biotherapeutics, Inc.
BOLT
$5.64
-$0.13-2.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.35M | -63.12M | -65.09M | -66.17M | -63.03M |
| Total Depreciation and Amortization | 1.72M | 1.78M | 1.82M | 1.84M | 1.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.27M | 8.49M | 7.84M | 8.23M | 7.38M |
| Change in Net Operating Assets | -3.55M | -8.44M | -5.71M | -7.82M | -9.08M |
| Cash from Operations | -57.90M | -61.29M | -61.12M | -63.91M | -62.88M |
| Capital Expenditure | -41.00K | -41.00K | -47.00K | -171.00K | -203.00K |
| Sale of Property, Plant, and Equipment | 1.11M | 148.00K | 148.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.85M | 57.47M | 61.05M | 56.84M | 52.45M |
| Cash from Investing | 61.92M | 57.58M | 61.15M | 56.67M | 52.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 108.00K | 108.00K | 185.00K | 185.00K | 253.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.00K | 108.00K | 185.00K | 185.00K | 253.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.13M | -3.61M | 214.00K | -7.05M | -10.37M |